Literature DB >> 20803656

Transient neonatal diabetes mellitus type 1.

Deborah J G Mackay1, I Karen Temple.   

Abstract

Transient neonatal diabetes mellitus type 1 (TNDM1) is a rare but remarkable form of diabetes which presents in infancy, resolves in the first months of life, but then frequently recurs in later life. It is caused by overexpression of the imprinted genes PLAGL1 and HYMAI on human chromosome 6q24. The expression of these genes is normally restricted to the paternal allele as a result of maternal DNA methylation. TNDM1 is not associated with mutation of PLAGL1 or HYMAI, but rather with their overexpression via uniparental disomy, chromosome duplication, or relaxation of imprinting. Study of patients with TNDM1 has provided valuable insights into the causes of imprinting disorders. Over half of patients with maternal hypomethylation at the TNDM1 locus have additional hypomethylation of other maternally methylated imprinted genes throughout the genome, and the majority of these patients have mutations in the transcription factor ZFP57. TNDM1 with maternal hypomethylation has also been observed in patients conceived by assisted reproduction, and in discordant monozygotic twins. The variable clinical features of TNDM1 may be associated with variation in the nature of the underlying epigenetic and genetic mutations, and future study of this disorder is likely to yield further insights not only into the biological mechanisms of imprinting, but also into the contribution of epigenetics to diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20803656     DOI: 10.1002/ajmg.c.30272

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  32 in total

1.  An atomic model of Zfp57 recognition of CpG methylation within a specific DNA sequence.

Authors:  Yiwei Liu; Hidehiro Toh; Hiroyuki Sasaki; Xing Zhang; Xiaodong Cheng
Journal:  Genes Dev       Date:  2012-10-11       Impact factor: 11.361

Review 2.  Role of DNA methylation in imprinting disorders: an updated review.

Authors:  Amr Rafat Elhamamsy
Journal:  J Assist Reprod Genet       Date:  2017-03-09       Impact factor: 3.412

Review 3.  Management of diabetes mellitus in infants.

Authors:  Beate Karges; Thomas Meissner; Andrea Icks; Thomas Kapellen; Reinhard W Holl
Journal:  Nat Rev Endocrinol       Date:  2011-11-29       Impact factor: 43.330

Review 4.  Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment.

Authors:  Siri Atma W Greeley; Rochelle N Naylor; Louis H Philipson; Graeme I Bell
Journal:  Curr Diab Rep       Date:  2011-12       Impact factor: 4.810

Review 5.  Economics of Genetic Testing for Diabetes.

Authors:  Rochelle Naylor
Journal:  Curr Diab Rep       Date:  2019-03-27       Impact factor: 4.810

6.  Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta.

Authors:  Isabel Iglesias-Platas; Alex Martin-Trujillo; Paolo Petazzi; Amy Guillaumet-Adkins; Manel Esteller; David Monk
Journal:  Hum Mol Genet       Date:  2014-07-03       Impact factor: 6.150

Review 7.  Role of ZAC1 in transient neonatal diabetes mellitus and glucose metabolism.

Authors:  Anke Hoffmann; Dietmar Spengler
Journal:  World J Biol Chem       Date:  2015-08-26

8.  Segmental Maternal UPD6 with Prenatal Growth Restriction.

Authors:  G Poke; M Doody; J Prado; M Gattas
Journal:  Mol Syndromol       Date:  2012-11-20

9.  Hypoglycaemia following diabetes remission in patients with 6q24 methylation defects: expanding the clinical phenotype.

Authors:  S E Flanagan; D J G Mackay; S A W Greeley; T J McDonald; V Mericq; J Hassing; E J Richmond; W R Martin; C Acerini; A M Kaulfers; D P Flynn; J Popovic; M A Sperling; K Hussain; S Ellard; A T Hattersley
Journal:  Diabetologia       Date:  2012-10-31       Impact factor: 10.122

Review 10.  New opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism.

Authors:  Adrian Kee Keong Teo; Amy J Wagers; Rohit N Kulkarni
Journal:  Cell Metab       Date:  2013-09-12       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.